Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Founder of HedgeFund Snared In Scandal Plots Return.
(WSJ, September 2018)
Jacob Gottlieb, who liquidated his firm Visium after an insider-trading scandal, eyes health-care stocks...
Mr. Gottlieb has formed a family office called Altium Capital that mostly manages his personal wealth and employs about six people. The firm, like Visium, focuses on health-care investing.
https://www.wsj.com/articles/visium-founder-is-plotting-a-return-to-the-hedge-fund-industry-1536355858
I posted evidence of suspended/terminated/withdrawn trials 1-year ago
...but pumpers rejected the evidence and refused to even make the necessary calls/correspondence to the facilities offering Delcath's Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma.
It was easy to make these connections Then and no one should be surprised Now.
.
Who'd have guessed all these things could happen?
Anyone could have and did.
Who'd have 'hoped' this wouldn't happen? - Everyone who's been here for at least last couple years.
If anyone's at all familiar with Delcath's operating tactics, they'd have to be blind or in total denial to be surprised by this or anything shady this scam company does.
.
I fail to see the relevance of your question. I've been thru as many bounces here as have you.
I've also been thru as much fraud here as you. Difference is, I did something about it.
More developments on the way.
I cannot disclose.
Laughing for long time.
.
Bounces here mean nothing to me. I settled out of court.
Getting my bounces elsewhere in non-scam company stocks.
What astounds me is the level of surprise that recent events here have stirred.
Somebody here said, he who laughs last ....
laughs the loudest
and the best.
I am laughing.
These posts are schizophrenic.
Undisclosed salvation investor?
Someone said, "who'd invest $1.5M in a bankrupt company?"
The only time(s) that's happened before in Delcath history is because the "do-gooder" knew he'd make tons back shorting.
If it's a lifeline, it's a lifeline to keep a sham company operational for the crooks.
It's not because of the increasingly obsolete product.
.
A Hint for certain curious Delcath investors:
SEC Awards $50 Million to Two Whistleblowers
FOR IMMEDIATE RELEASE
2019-42
Washington D.C., March 26, 2019 —
The Securities and Exchange Commission today announced awards totaling $50 million to two whistleblowers whose high-quality information assisted the agency in bringing a successful enforcement action. One whistleblower received an award of $37 million and the other received an award of $13 million. The $37 million award is the Commission’s third-highest award to date after the $50 million award made in March 2018 to joint whistleblowers and more than $39 million award announced in September 2018.
I'm laughing and I'll have the last laugh.
I posted that I got all my losses back plus extra.
Regardless of my new fresh lifetime average, I cannot lose.
I'm only in it for the train wreck that is comingggggggg.
I'll still be laughing and in the green.
I don't and never have grasped at straws
to make any negative observation about Delcath company.
I made money on that fluke spike as well. I rode it from
.02 to.30.
I then became over-enthusiastic and bought back-in.
Afterwards, more thorough and ongoing research and investigation of the company made it perfectly clear that there was no need to grasp at straws in order to inhale the stench of something rotten in Delcath.
I made a bad re-investment decision and that was a lesson learned. My lack of due diligence in that matter does Not excuse their operating tactics.
Risk is involved in any investment but that brand of 'acceptable' risk is separate from the risk of fraudulent behavior and willful mismanagement.
I don't regret the lesson learned with lost money...and I won't refrain from digging-up the dirt on this company. I'll merely refrain from posting all new evidence as I agreed to do.
Besides, every investor can research and investigate in order to uncover and/or 'profit' from the treasure to be found with a little time and elbow grease.
.
The discussion was about all-time lows.
The discussion brought to memory the fluke run from approx .02 to .36 back 2 summers ago.
That was the sole intent of the post, Mr.Grease.
That's about the time many existing investors boarded the sinking ship called Delcath.
.
Continued from previous post:
July, 2017 (continued)
Delcath Systems (OTC:DCTH) is an interventional oncology company focusing on the treatment of liver cancer. It is still doing trials on its Melblez Kit filter system that was failed to be approved by the FDA way back in 2013. The stock is up 1000% over the past month on no news, just recently created hype. The stock closed yesterday at $0.18, reached over $0.30 on June 21st, and was trading between $0.02-$0.04 between May 11th and June 8th.
How many of us here now remember this?
From Seeking Alpha July, 2017
Delcath Systems Share Price Has Risen Over 1000% In The Past Month On No News And Is Engaged In Death Spiral Financing
Jul. 12, 2017 11:04 AM•DCTH
Summary
In the past month, Delcath has risen 1000% on promotional hype and no fundamental news.
It's engaging in death spiral financing, and the convertible note holders can buy shares at a 15% discount to the recent market price and immediately sell.
Delcath’s outstanding share count went from 39 million on February 10, 2017, to 374.4 million on June 5th, 2017, to 439.8 million on July 5, 2017.
Delcath is conducting clinical trials on its same technology that the FDA failed to approve in 2013.
.
Despite being a struggling company, Delcath's high spending executives award themselves high salaries, fly first class, and its HQ is located in expensive midtown Manhattan.
I've asked for an opinion on this recently ... but never received any response.
My question comes to mind again today with the latest news release:
http://delcath.com/investors-news/
Why is it that we never recognize the already FDA-approved procedure known as "Chemoembolization" which has been being used for metastatic liver cancer (including ocular melanoma) for quite some time.
The treatment/procedure is also known as "TACE".
The specialists I've spoken to at Mayo Clinic and Piedmont are not highly impressed with PHP trials. Perhaps they know something that the typical Delcath enthusiast does not;
after all, it's they're job to "know".
Beg to differ. It happens and Will happen...
with Delcath.
Tick tock.
.
My take is that a skunk by any other name will still smell as foul.
.
m_maker, what's your understanding of the procedure known as Transcatheter Arterial Chemoembolization (TACE) and what's your opinion on how this already-approved technique and its success-record compares to and/or impacts the prospects for Chemosat?
Very well said, DE.
.
Evidently not... the user to whom I responded didn't think so.
Really doesn't matter; time will tell all.
Medac deal is highly speculative and proves nothing.
It's your money.
Respectfully, not sure you meaning of blackmail.
I was offered a settlement with the agreement that I'd not post newfound evidence regarding Delcath on message boards and websites.
I am still able to report all findings to any and all authorities...and I am.
.
Delcath is hiding behind the phrase "saving lives".
They are, in fact, holding the product hostage for their own financial gain...which is the opposite of being great and is certainly not saving nearly enough lives due to their malfeasances.
.
When was Delcath ever Great?
I remember a few fluke spikes along the way...as can happen accidentally with Any poorly-managed, doomed company...but I cannot recall anything resembling Greatness.
.
I think Delcath released this PR in 2010...(if I'm not mistaken)...almost exactly 9 years ago.
Granted, they've had major setbacks since then, but when you inspect closely there's no way to deny that they could've better and sooner recovered from the filter and other such setbacks if current management were more interested in expanding usage than in using the company and product as a vehicle for personal gain.
Time and technology marches on and I believe they're content to squeeze every illegitimate dollar out of this vehicle until new science makes the product obsolete.
.
.
TTS, Yes. I think someone or two or more will shut Delcath down.
.
I've often wondered that myself.
Unfortunately, I honestly don't think Delcath's leadership cares that much about the viability and usefulness of the product other than using it as a vehicle to commit fraud.
If they'd commit as much time to advancing the product any further than needed for their own personal gain, the treatment may very well prove to be of value to many more patients other than those with a specific, rare cancer.
.
You'd have the details regarding Delcath had my posts not been deleted. But nothing I'd shared was anything you cannot easily discover yourself.
My integrity is not the issue and that remark doesn't yank my chain if it was supposed to.
The truth is out there for anyone who looks for it hard enough and the opportunity to report malfeasance and derilection of duty is available to every shareholder.
Enjoy your evening.
.
.
No, Delcath settled with Me out-of-court.
I'm not referring to HB.
Imo, you knew exactly what I was referring to.
The entire HB situation was child's play.
Delcath does Not want investors knowing how they're operating and they'll do whatever it takes to cover-up their dereliction of fiduciary duty.
All investors and certainly all posters on this forum can uncover the truth(s) if they look close enough and all individual investors can report the malfeasances to proper authorities, post them publicly and confront Delcath in the same manner.
This is why Delcath so eagerly settled out-of-court.
Good job and great post, DE.
Simpson and crew become very nervous when go-getters post or otherwise publicize their devious tactics.
Any investor, seasoned or green, can find this type of information on their own without being hand-held and guided to the truth if they'll only do a little diligent digging on their own.
Delcath's days are numbered.
That doesn't mean that, with perfect technical timing, one couldn't catch a small spike if... if and Only IF....they get very lucky and can easily afford to lose their entire investment.
.
.
Evidence was submitted to all proper authorities and continues to be submitted. My agreement with Delcath was that I would cease sharing "evidence" (specifically, evidence not already shared and posted) to message boards and to agree to not upload any previously unshared or "new" evidence to existing shareholder-advocate websites. I've adhered to my end of the agreement.
.
Those sites cannot be trusted. We've known that for at Least 2+ years regarding Delcath and they've been wrong about their other prognostications.
If, by chance, Anything these sites predict come to pass, it is purely Accidental.
.
.
My thoughts exactly.
.
Investors profit on bankruptcy-bound company-stock every day.
It's all in how you flip it during the ensuing chaos.
It would be dishonest to pretend that a bankruptcy-bound company wasn't bound for doom simply because You were profiting or Hoping to profit from any fluke spikes on the way.
.
Right, DE. Don't think they want NASDAQ.
They want as little transparency as possible, of course.
.
Are you sure they Want relisting on NASDAQ?
Seems like they quite Enjoy flying dark under the radar on OTC.
.
Indeed. 2K is a healthy-enough position as I expect you can afford to lose at least that much.
Good luck!
Absolutely. And oftentimes, with shady companies, the company is in-on the shorting.
It's no secret that I consider Delcath "shady" so, Imo, that is how Delcath could "benefit" from a reverse split... Yet again.
Imo, that's a great question.
Whereas a legit company would
enact a reverse split because it needs to get its share price up to meet a listing requirement,
it often (perhaps even usually) benefits shorts because the SP usually falls sharply.
Maybe that's the real reason behind any potential upcoming RS...that is, perhaps they're planning to engage in more pillow-talk... snuggling with the shorts.
New 8-K just out:
Item 1.02. Termination of a Material Definitive Agreement.
On January 18, 2019, Delcath Systems, Inc. (the “Company”) terminated the Backstop Commitment Purchase Agreements (the “Agreements”) with three institutional investors, by their mutual agreement. The Agreements were terminated as a result of the closing price of the Company’s common stock not exceeding the Subscription Price since October 1, 2018, so the Purchasers have in no way been required to purchase Purchase Shares under Section 9(d) the Backstop Agreements during any period during which the Agreements would have been deemed effective to date.
As of the date of this Current Report on Form 8-K, the Company has 11,163,954 shares of its common stock outstanding.